HKTDC MarketingPulse and eTailingPulse attract over 1,400 global industry professionals
HONG KONG, Mar 15, 2023 – (ACN Newswire) – Organised by the Hong Kong Trade…
HONG KONG, Mar 15, 2023 – (ACN Newswire) – Organised by the Hong Kong Trade…
Human Performance Leader Will Continue to Expand 1:1 Coaching and Deliver New World-Class Products for…
Unique, strategic cyber intelligence provides value across operating teams NEW YORK, March 15, 2023 (GLOBE…
Unique, strategic cyber intelligence provides value across operating teams NEW YORK, March 15, 2023 (GLOBE…
CARLSBAD, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,”…
CARLSBAD, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,”…
JUPITER, Fla., March 15, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”,…
JUPITER, Fla., March 15, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”,…
Four differentiated clinical compounds progressing through Phase 1 towards key data milestones Eight abstracts accepted…
Four differentiated clinical compounds progressing through Phase 1 towards key data milestones Eight abstracts accepted…
Results to be presented from a survey designed to quantify treatment preferences of healthcare providers…
Results to be presented from a survey designed to quantify treatment preferences of healthcare providers…
Avextra announces the closing of its EU 17 Million Convertible Loan Note (“CLN”) bridge capital…
Avextra announces the closing of its EU 17 Million Convertible Loan Note (“CLN”) bridge capital…
Management to host conference call and webcast at 4:30 p.m. ET BURLINGTON, Mass., March 15,…
Management to host conference call and webcast at 4:30 p.m. ET BURLINGTON, Mass., March 15,…
WAKEFIELD, MA, March 15, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the…
WAKEFIELD, MA, March 15, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the…
In combination with gilteritinib Primary objectives: to assess safety, tolerability and RP2D Secondary objectives: to…
In combination with gilteritinib Primary objectives: to assess safety, tolerability and RP2D Secondary objectives: to…